The company provides digital government-to-citizen services and financial infrastructure, including PAN card processing, Aadhaar registration, and banking correspondent services for major Indian banks.
The business relies on regulatory licenses and a large physical network of service points, but the lack of durable high margins or pricing power suggests these are commodity-like services with low switching costs. While the network is extensive, it does not translate into a wide competitive advantage as evidenced by fluctuating profitability.
Capital is primarily used to fund a complex web of related-party transactions and to capitalize internal technology development. The recent plan to invest 70 crore INR into a subsidiary to meet regulatory net-worth requirements for a new business line indicates a shift toward diversification rather than returning cash to shareholders.
The investment collapsed as the massive 164.7 crore INR tax liability was upheld, wiping out the company's net worth and liquidity. Management's pattern of funneling capital into related-party transactions and un-titled real estate assets left the firm with no cushion when regulatory scrutiny intensified. The business, already struggling with poor cash conversion and weak pricing power, became a hollow shell as the promoter-linked loans were never recovered and the core service network was commoditized by more efficient, transparent competitors.
RichFakir rates Alankit Ltd's business quality as poor — 21/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Alankit Ltd is trading about 37% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Alankit Ltd is: Not rated. Poor business (score 21), but the valuation is low-confidence, so we are not calling it a bargain.
RichFakir's educational estimate of Alankit Ltd's fair value is about ₹11 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →